29 July 2016 - Deborah Wilkes
Archived
Worldwide sales at GlaxoSmithKline's Consumer Healthcare business grew by 7% at constant exchange rates to £1.69 billion (US$1.88 billion) in the second quarter of 2016. The company said growth had been driven by its Oral Health and Wellness powerbrands.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.